Updates and Events
Empire State Building Lights Up for Lupus

Nov. 21, 2017. The Empire State Building lit up purple and red last night in honor of the Lupus Research Alliance and our Lupus Breaking Through Gala that celebrates the power of science! The beacon of hope shone bright for the lupus community, raising awareness of the disease and the critical importance of lupus research. […] READ MORE

Lupus Research Alliance Sponsors the 2017 Forum For Discovery: Frontiers in Immune Regulation

LUPUS RESEARCH ALLIANCE SPONSORS THE 2017 FORUM FOR DISCOVERY: FRONTIERS IN IMMUNE REGULATION Visionary Scientists and Industry Leaders Report on Promising Advances and Future Directions in Lupus Research Nov. 16, 2017.  Last month, 150 dedicated research scientists, pharmaceutical industry representatives, and Lupus Research Alliance advocates met in New York City at the 2017 Forum for […] READ MORE

Lupus Research Alliance Announces Awards to Uncover Causes of Lupus

Two Outstanding Scientists Recognized for Transformative Lupus Research Projects Nov. 09, 2017. The Lupus Research Alliance is proud to announce the 2017 recipients of the Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity. Michael Carroll, PhD, Children’s Hospital Boston, is studying why and how lupus attacks the brain and central nervous system […] READ MORE

STELARA® Shows Positive Results

STELARA® (Ustekinumab) Shows Positive Results in Treatment of Systemic Lupus Erythematosus in Phase 2 Trial   60 percent of patients receiving STELARA® showed significant reductions in lupus disease activity vs. 31 percent of patients receiving placebo STELARA® showed significant improvements in various disease measures compared with placebo, including musculoskeletal, mucocutaneous, immunological markers and flares Janssen […] READ MORE

Lupus Research Alliance Prompted Stelara® Study for Lupus

Lupus Research Alliance welcomes compelling new data, presented at the American College of Rheumatology (ACR) annual meeting that demonstrated significant benefit for lupus patients treated with Stelara® (ustekinumab), a prescription medicine from the Janssen Pharmaceutical Companies. Stelara® is not approved for the treatment of lupus, but is approved by the FDA for certain autoimmune diseases. Through its drug repurposing program, the Lupus Research Alliance first identified Stelara® as a potential treatment for lupus and encouraged Janssen to pursue testing for this use. READ MORE

Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies

NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN) aimed at discovering new treatments for the millions of people around the globe living with lupus. Recognizing the limited treatments for lupus, LuCIN was organized, managed and is […] READ MORE

Pour for a cure

Join us at a private home in beautiful Santa Rosa hill country, decked out in your best diamonds and denim, for the inaugural Pour for a Cure – Taste Wine, Fight Lupus event. Your support will help patients locally as well fund important research towards a cure. POUR WITH US! > September 9, 2017 12 […] READ MORE

Breaking Through Gala

Please join us for a breakthrough evening celebrating the power of science. Monday, November 20, 2017 6:30 PM – Cocktails 7:30 PM – Dinner Ziegfeld Ballroom 141 West 54th Street, New York City HONORING Steve Burke, CEO, NBCUniversal DISTINGUISHED SERVICE AWARD Margaret G. Dowd, Immediate Past Co-President and CEO, Lupus Research Alliance HOST Seth Myers, […] READ MORE

Together, ManyOne Can make a difference!
Stay informed about events, research developments, and ways you can help. Sign up for updates